ACTIVE_NOT_RECRUITING

Lung Transplant READY CF 2: A Multi-site RCT

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. More than half of people with CF who die without a lung transplant were never referred for consideration. Patient preference not to undergo lung transplant may account for 25-40% of decisions to defer referral. Rates of death without transplant are higher for people with CF who are members of marginalized communities, including those with Black race, Hispanic ethnicity, or low socioeconomic status. Increasing awareness of lung transplant among people with CF, and promoting understanding of the risks and benefits of transplant, can potentially reduce the number of people with CF who die without a lung transplant. The CF Foundation (CFF) lung transplant referral guidelines were developed to optimize the timing of referral for lung transplant. These guidelines recommend annual conversations with people with CF once their forced expiratory volume in one second (FEV1) is \<50% predicted. Considering lung transplant as a treatment option before it is medically needed will allow more time to learn about lung transplant and address any barriers to lung transplant that may exist. Investigators are interested in understanding how people with CF use lung transplant educational resources and how one prepares for having discussions and/or making decisions about lung transplant as a treatment option for advanced CF. The purpose of this study is to test whether a research website improves patient preparedness for discussions about lung transplant. Investigators also aim to understand whether there are unique factors that affect people with CF from communities with decreased access to transplant ("communities of concern"). Study involvement will span 6 months and study activities will involve the following: * Four Zoom research sessions (15-30 minutes each) * Survey assessments * Access to a research website that contains educational resources about lung transplant * Audio recording of a routine CF clinic visit to determine if and how lung transplant is discussed between a participant and his/her/their CF doctor

Official Title

Preparation for Lung Transplant Discussions and Decisions Among People With Cystic Fibrosis

Quick Facts

Study Start:2023-09-06
Study Completion:2027-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06030206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of cystic fibrosis
  2. * FEV1 less than 50% of predicted
  1. * People who are unable to provide informed consent
  2. * People who are lung transplant recipients
  3. * Unable to read or understand English or Spanish to complete surveys or access the website (currently only available in English and Spanish)

Contacts and Locations

Principal Investigator

Kathleen Ramos, MD, MSc
PRINCIPAL_INVESTIGATOR
University of Washington

Study Locations (Sites)

University of California at Los Angeles (UCLA)
Los Angeles, California, 980095
United States
National Jewish Health
Denver, Colorado, 80206
United States
Yale University
New Haven, Connecticut, 06520
United States
University of Kansas
Kansas City, Kansas, 66160
United States
Maine Health
Portland, Maine, 04102
United States
Johns Hopkins University
Baltimore, Maryland, 21205
United States
University of Minnesota
Minneapolis, Minnesota, 55455
United States
University of Cincinnati
Cincinnati, Ohio, 45267
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213
United States
Baylor College of Medicine
Houston, Texas, 77030
United States
University of Washington Medical Center - Montlake
Seattle, Washington, 98195
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Kathleen Ramos, MD, MSc, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-06
Study Completion Date2027-05-31

Study Record Updates

Study Start Date2023-09-06
Study Completion Date2027-05-31

Terms related to this study

Keywords Provided by Researchers

  • Cystic Fibrosis
  • Lung Transplantation
  • Advanced Lung Disease
  • Decision Support Tool

Additional Relevant MeSH Terms

  • Cystic Fibrosis